Core Health & Medical Ltd Announces Strategic Expansion to Transform Cancer Care in Canada, a forward thinking healthcare company focused on advanced oncology solutions, today announced its strategic initiative to expand access to cutting-edge cancer treatment technologies across Canada.
With a strong commitment to improving patient outcomes, CHML is pioneering efforts to introduce Proton Beam Therapy (PBT) one of the most advanced and precise forms of radiation treatment available globally. This initiative aims to significantly reduce the need for Canadian patients to seek treatment abroad, while enhancing the quality and accessibility of care domestically.
Access to advanced cancer treatment should not be limited by geography of Core Health & Medical Ltd. Our mission is to ensure patients receive world-class care within their own country, supported by innovative technology and expert medical teams.
Proton Beam Therapy offers unparalleled precision by targeting tumors while minimizing damage to surrounding healthy tissue. This is particularly beneficial for pediatric patients and individuals with complex or high risk cancer cases.
In addition to its focus on treatment, CHML is investing in state of the art medical imaging solutions designed to accelerate diagnosis and reduce waiting times two critical factors in improving cancer survival rates.
The company’s integrated approach emphasizes:
Faster access to specialized oncology services
Reduced patient burden and travel costs
Improved treatment accuracy and outcomes
Enhanced coordination across the care continuum
Core Health & Medical Ltd continues to position itself as a leader in healthcare innovation, working collaboratively with medical professionals, institutions, and strategic partners to strengthen the oncology landscape in Canada.
As demand for advanced cancer care grows, CHML remains dedicated to delivering scalable, patient-centered solutions that will shape the future of healthcare.
About Core Health & Medical Ltd
Core Health & Medical Ltd is a healthcare company based in Edmonton, Alberta, specializing in advanced cancer treatment and medical imaging solutions. The company is committed to improving access to innovative oncology care through the development of cutting-edge technologies and infrastructure.
